These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. HLA typing on Italian multiple sclerosis population. Zibetti A; Cazzullo CL; Smeraldi E; Scorza-Smeraldi R Boll Ist Sieroter Milan; 1978 Jan; 56(6):539-43. PubMed ID: 147093 [TBL] [Abstract][Full Text] [Related]
8. Proceedings: Multiple sclerosis susceptibility and histocompatibility determinants. Alter M; Harshe M; Yunis EJ Neurology; 1975 May; 25(5):489. PubMed ID: 1169709 [No Abstract] [Full Text] [Related]
9. HLA-A & HLA-B antigens in multiple sclerosis, motor neuron disease & Duchenne muscular dystrophy. Mehta MM; Chablani UA; Contractor NM; Bhatia HM; Singhal BS; Mondkar VP; Desai AD Indian J Med Res; 1986 May; 83():519-21. PubMed ID: 3733208 [No Abstract] [Full Text] [Related]
10. [Immunogenetic analysis of multiple sclerosis]. Govaerts A Bull Mem Acad R Med Belg; 1983; 138(4):300-5. PubMed ID: 6640186 [No Abstract] [Full Text] [Related]
11. Tumor necrosis factor-alpha and disease progression in multiple sclerosis. Liblau RS; Fugger L N Engl J Med; 1992 Jan; 326(4):272-3. PubMed ID: 1727983 [No Abstract] [Full Text] [Related]
12. [Aspects of antiviral immunity in patients with multiple sclerosis]. Mayer M Cas Lek Cesk; 1985 Jul; 124(28):869-71. PubMed ID: 2411404 [No Abstract] [Full Text] [Related]
13. [Myasthenia-multiple sclerosis: a possible pathogenetic relationship?]. De Meyer F; Maquet JC; Gyselings R Rev Med Brux; 1988 Sep; 9(6):321-5. PubMed ID: 3051249 [No Abstract] [Full Text] [Related]
14. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145 [TBL] [Abstract][Full Text] [Related]
15. The contribution of HLA to multiple sclerosis susceptibility in Sardinian affected sibling pairs. Marrosu MG; Fadda E; Mancosu C; Lai M; Cocco E; Pugliatti M Ann Neurol; 2000 Mar; 47(3):411-2. PubMed ID: 10716270 [No Abstract] [Full Text] [Related]
16. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases. Lobnig BM; Chantelau E; Vidgrén G; Van Landeghem AA; Kinnunen L; Tuomilehto-Wolf E Diabetes Metab; 2002 Jun; 28(3):217-21. PubMed ID: 12149602 [TBL] [Abstract][Full Text] [Related]
17. Histocompatibility antigens (HLA) in multiple sclerosis in Iran. Lotfi J; Nikbin B; Derakhshan I; Aghai Z; Ala F J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):699-701. PubMed ID: 681957 [TBL] [Abstract][Full Text] [Related]
18. HLA and multiple sclerosis in Italy. Two population studies in northern and insular Italy. Granieri E; Conighi C; Tola R; Carreras M; Rosati G; Paolino E; Vicentini V; Grappa MT; Mattiuz PL Acta Neurol (Napoli); 1987 Apr; 9(2):124-33. PubMed ID: 3508348 [No Abstract] [Full Text] [Related]
19. HLA studies on multiple sclerosis in Japan. Saito S; Naito S; Kawanami S; Kurowa Y Neurology; 1976 Jun; 26(6 PT 2):49. PubMed ID: 944894 [No Abstract] [Full Text] [Related]
20. Segregation of HLA type in multiple sclerosis families. Karis R Ann Neurol; 1978 Aug; 4(2):156-7. PubMed ID: 707989 [No Abstract] [Full Text] [Related] [Next] [New Search]